IKC Annual Review 2016 1 | Page 20

Medical Technologies IKC | 20 Building community Where are they now? The support of the Medical Technologies IKC goes beyond advancing technologies, products and services: we seek to ensure that those involved with every stage of the translational research pipeline can benefit professionally from their experience of working with us. Our proof of concept partners have pursued a variety of fascinating career paths in the last 12 months: Was: Research & Technical Manager at Tissue Regenix Ltd Now: University Academic Fellow in Cardiovascular Regenerative Therapies & Devices, University of Leeds “ In my past roles within the University of Leeds and the spin-out company, Tissue Regenix, I was fortunate enough to directly contribute to the successful translation of a research concept through to delivery of a regulatory-approved clinical product. The experience of working in a spin-out company, from its inception to international expansion, was invaluable in understanding translational and commercial challenges and developing partnerships. It allowed me to develop skills in new product development, establishing quality systems, managing teams, conducting collaborative research, and identifying clinical needs and potential solutions. Working in partnership with the University kept me connected to my real passion – fundamental and applied research – prompting a return to academia when the opportunity arose. The insights and skills gained from my roles in industry will help inform the future development of regenerative devices and assist in addressing translational challenges. “ Dr Helen Berry